Human Genome Epidemiology Literature Finder
|
Records 1 - 4 (of 4 Records) |
| Query Trace: Neoplasms and MTHFD2[original query] |
|---|
| A candidate CpG SNP approach identifies a breast cancer associated ESR1-SNP. International journal of cancer. Journal international du cancer 2011 Oct 129 (7): 1689-98. Harlid Sophia, Ivarsson Malin I L, Butt Salma, Hussain Shehnaz, Grzybowska Ewa, Eyfjörd Jorunn Erla, Lenner Per, Försti Asta, Hemminki Kari, Manjer Jonas, Dillner Joakim, Carlson Joy |
| Somatic mutations in early onset luminal breast cancer. Oncotarget 2018 Apr 9 (32): 22460-22479. Encinas Giselly, Sabelnykova Veronica Y, de Lyra Eduardo Carneiro, Hirata Katayama Maria Lucia, Maistro Simone, de Vasconcellos Valle Pedro Wilson Mompean, de Lima Pereira Gláucia Fernanda, Rodrigues Lívia Munhoz, de Menezes Pacheco Serio Pedro Adolpho, de Gouvêa Ana Carolina Ribeiro Chaves, Geyer Felipe Correa, Basso Ricardo Alves, Pasini Fátima Solange, Del Pilar Esteves Diz Maria, Brentani Maria Mitzi, Guedes Sampaio Góes João Carlos, Chammas Roger, Boutros Paul C, Koike Folgueira Maria Aparecida Azeve |
| Regulation and Therapeutic Targeting of MTHFD2 and EZH2 in KRAS-Mutated Human Pulmonary Adenocarcinoma. Metabolites 2022 7 12 (7): . Li Yuchan, Elakad Omar, Yao Sha, von Hammerstein-Equord Alexander, Hinterthaner Marc, Danner Bernhard C, Ferrai Carmelo, Ströbel Philipp, Küffer Stefan, Bohnenberger Hanib |
| Overexpression of MTHFD2 represents an inflamed tumor microenvironment and precisely predicts the molecular subtype and immunotherapy response of bladder cancer. Frontiers in immunology 2023 12 14 1326509. Xiaokai Shi, Xiangrong Peng, Yin Chen, Zebin Shi, Chuang Yue, Li Zuo, Lifeng Zhang, Shenglin G |
- Page last reviewed:Feb 1, 2024
- Content source:

